Adherium, a New Zealand-based maker of connected respiratory medical devices, has received the US Food and Drug Administration's 510(k) clearance for connecting its digital monitoring platform with GlaxoSmithKline’s range of Ellipta dry powder inhalers.
The ASX-listed firm offers the Hailie sensor which attaches to an inhaler to remotely monitor and capture medication usage parameters and...
Human API, maker of a consumer-facing health data sharing platform, announced last week the close of "over $20 million" in Series C funding. The raise saw backers Samsung Ventures, CNO Financial Group, Allianz Life Ventures and Moneta VC joining returning investors BlueRun Ventures, SCOR Life and Health Ventures, and Guardian Life Insurance Company.
The company's tools connect to a range of data...
Babyscripts announced today that its prenatal app has become available to mothers and doctors at the Froedtert & Medical College of Wisconsin health network. Later this year the network will also enable mothers to opt into the service’s data sharing component to allow remote patient monitoring tool for OB/GYNs.
“Expectant patients are now able to access evidenced-based education anytime to...
Bankrupting docs? Patient booking platform Zocdoc is putting providers in a sticky situation, CNBC reports. The platform, which lets patients book and cancel appointments, is changing its business model. Now instead of charging providers a flat annual rate per doctor, it proposes to charge a lower annual rate as well as a booking fee for each new customer.
Not only would this dramatically...
Connected inhaler sensor maker Adherium has received 510(k) clearance for US over-the-counter sales of its Hailie sensor, formerly known as Smartinhaler. Specifically, individual versions of the device have been cleared for use with the asthma inhalers ProAir HFA, Ventolin HFA, and Flovent HFA.
“This latest clearance kicks off our official entry into the US consumer market, giving the tens of...
Interest in digital health is now sprouting up all over DC, from the president’s announcement of a new AI task force to FDA Commissioner’s shout out to digital health in his budget request.
In fact, the FDA is turning to developers in the digital health space to help solve some of the country’s most difficult problems. In May, the agency announced an innovation challenge aimed at tackling the...
Smart inhaler company Adherium announced last week that it has received 510(k) clearance for over-the-counter sales of its inhaler monitoring device for AstraZeneca’s Symbicort aerosol inhaler, called the SmartTouch for Symbicort.
Adherium — which is headquartered in San Mateo, California, but holds currently offices in Melbourne, Australia; Auckland, New Zealand; and Amstelveen, The Netherlands...
Yesterday, Dr. Brenda Fitzgerald resigned from her position as director of the Centers for Disease Control and Prevention following a Politico report that she had purchased shares of a tobacco company within a month of appointment. Since July, Fitzgerald has often been unable to attend several hearings due to conflicts of interest from other holdings, drawing ire from some of her colleagues in...
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.
“We’ve had a great relationship over the last couple of years with AstraZeneca, we’ve launched in a couple dozen countries now...
Health enterprise software company Welltok has hired a new chief financial officer. Chris Power previously served as CFO at a number of companies including Paycor and LifeLock, both of which are software as a service companies.
“Chris is an exceptional leader who brings tremendous financial depth and operating know-how to our fast-growing organization,” Jeff Margolis, chairman and CEO of Welltok...
